Blog
1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17?
On March 4, analyst Joseph Pantginis at HC Wainwright opined that shares of Iovance Biotherapeutics (NASDAQ: IOVA) would reach $32, an increase of 91% beyond its current price near $17.
There are a
Massive News for Palantir Stock Investors
In this video, I will talk about Palantir (NYSE: PLTR), the reason why Ontology is so important, a couple of big new partnerships, and a look at Palantir stock from a technical analysis standpoint.
This 1 Chart Shows How Microsoft Became the Biggest "Magnificent Seven" Stock and World's Most Valuable Company
Earlier this year, Microsoft (NASDAQ: MSFT) dethroned Apple (NASDAQ: AAPL) to become the world's most valuable company. With a market capitalization of roughly $3 trillion, Microsoft is currently
Prediction: This Unstoppable AI Trend Could Make Bitcoin Even More of a No-Brainer Investment Than It Already Is
When most investors think of big catalysts capable of pushing Bitcoin (CRYPTO: BTC) to new stratospheric highs, they typically focus on events such as the rollout of the new spot Bitcoin
2 Trillion-Dollar "Magnificent Seven" Stocks to Buy Hand Over Fist in March
The "Magnificent Seven" is the apt moniker placed on a group of seven of the world's largest technology companies:
The Magnificent Seven stocks delivered an average return of 112.7% in 2023, handily
Rithm Capital's Evolution Positions It to Capitalize on This $24.5 Trillion Market Opportunity
Rithm Capital (NYSE: RITM) started writing a new chapter last year. The real estate investment trust (REIT) acquired Sculptor Capital Management for around $720 million to launch the next stage of
Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street
A bull market is here, but not every stock is benefiting. Some players remain in the doldrums. It's up to investors to decide whether those left behind are likely to remain there or make top buying
Want $1,000 in Safe Annual Dividend Income? Invest $11,150 Into the Following 3 Ultra-High-Yield REITs.
Regardless of your investment style or risk tolerance, Wall Street offers an abundance of ways to grow your wealth. But among these seemingly countless strategies, few have proved more successful
Artificial Intelligence (AI) Stock Nvidia May Be the Bubble of the Century, and History Suggests It Won't End Well
Since this year began, the iconic Dow Jones Industrial Average, benchmark S&P 500, and growth-powered Nasdaq Composite have all put the 2022 bear market in the rearview mirror and catapulted to
Lawmakers Might Increase Social Security's Full Retirement Age to Avoid Benefit Cuts. Here's How That Could Hurt Today's Workers Big Time
Social Security is not in the best financial shape. The program gets the bulk of its funding from payroll taxes. But in the coming years, that revenue stream is expected to shrink as baby boomers
QuantumScape: This Move Might Change Everything
In this video, Motley Fool contributors Jason Hall and Tyler Crowe discuss how QuantumScape (NYSE: QS) co-founder Jagdeep Singh's decision to step back as CEO and promote a recent hire to the top
Is Abbott Laboratories a Top Dividend Growth Stock to Buy Now?
Dividend growth stocks are a powerful tool for wealth creation. The magic of compounding allows these high-quality dividend growers to provide exponential returns to their long-term shareholders.
1 Top Cryptocurrency to Buy Before It Soars 1,970% by 2030, According to Select Wall Street Analysts
The price of Bitcoin (CRYPTO: BTC) is determined by supply and demand. Its source code limits supply to 21 million coins, and 19.6 million of that total are already in circulation, meaning new
1 Warren Buffett Dividend Stock Up 25% That Still Looks Like a Bargain
Investors looking for a no-brainer dividend stock to buy and hold for the long run should look at Warren Buffett and the banking industry. During the first two quarters of 2023, Buffett's holding
AT&T Stock Has 25% Upside, According to This Wall Street Analyst
AT&T (NYSE: T) stock is going to hit a level it hasn't seen since June 2022. At least that's what analyst Peter Supino from Wolfe Research said when he upgraded shares of the telecommunications
1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.
With Citigroup analyst Samantha Semenkow calling on Feb. 29 for shares of Editas Medicine (NASDAQ: EDIT) to rise from their current price near $10 to reach $16 -- an increase of 45% over her prior
Got $20? Buy This Korean E-commerce Stock Before It's Too Late
Last week was a big one for Coupang (NYSE: CPNG). The Korea-based e-commerce platform reported its full-year earnings and saw its stock pop more than 10% after putting up strong growth and
Missed Out on Uber? Buy Grab Stock Instead
If you've held Uber Technologies (NYSE: UBER) shares for any meaningful length of time since the beginning of last year, congratulations! You've almost certainly made good money on your trade. Uber
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
Inovio Pharmaceuticals (NASDAQ: INO)Q4 2023 Earnings CallMar 06, 2024, 4:30 p.m. ET
Operator
Source Fool.com
Infinera (INFN) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
Infinera (NASDAQ: INFN)Q4 2023 Earnings CallMar 06, 2024, 5:00 p.m. ET
Operator
Source Fool.com
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
Emergent BioSolutions (NYSE: EBS)Q4 2023 Earnings CallMar 06, 2024, 5:00 p.m. ET
Operator
Source Fool.com
Why Nordstrom Stock Dropped Today
Shares of Nordstrom (NYSE: JWN) fell 16.1% on Wednesday after the department-store chain announced better-than-expected quarterly results but followed with underwhelming forward guidance.
For its
Why Foot Locker Stock Plunged Today
Shares of Foot Locker (NYSE: FL) plunged 29.4% on Wednesday after the company announced a large loss based on generally accepted accounting principles (GAAP) for the crucial holiday quarter and
Why Couchbase Stock Rocked the Market on Wednesday
Cloud database specialist Couchbase (NASDAQ: BASE) enjoyed a nice jump in share price on Wednesday following the release of its latest set of quarterly and annual financial results for fiscal 2024
Why Meta Platforms Stock Topped the Market Today
Meta Platforms (NASDAQ: META) had a good day both in terms of its operations and its stock performance. The social media giant's shares inched more than 1% higher, due in no small part to its


